, SAVE THE DATE: DADA2 Foundation Global Virtual Conference Experience

SAVE THE DATE

The 3rd International Conference on

Deficiency of Adenosine Deaminase 2:

Driving Toward Consensus

November 17,18 & 19, 2020

Daily I 8:30 a.m. - 11:30 a.m. eastern standard time (U.S.)

A Virtual Conference Experience for our entire

Clinical & Research Community

Dear Greetings!,

I'd like to invite you to SAVE THE DATE for the 3rd International Conference on DADA2.

We look forward to welcoming you and your fellow researchers and clinicians dedicated to finding a cure for this disease. While COVID-19 restrictions prevent our in-person gathering, we are pleased to open access via a virtual conference experience to our global community of hundreds of researchers and clinicians who are dedicated to this collaborative approach. Together, we will continue our work to improve the lives of DADA2 patients around the world.

Our meeting's focus will include new exciting research, as well as the continued improvements of diagnosing and treating patients with DADA2. Highlights of this year's discussion include:

Integration of recently published research into established understandings of DADA2
Exploration of differing viewpoints through intentional dialogue
Discussions of future establishment of a patient registry & biobank
Growth accomplished under our grant with the Chan Zuckerberg Initiative

These conversations are the starting point for our next critical milestone - a consensus statement for DADA2 in 2021.

If you know of a clinician or researcher who is not yet engaged in the DADA2 Foundation, but would like more information, please share this email with them and copy chip.chambers@dada2.org so we can follow up.

Cheers!

Chip Chambers, M.D.

Assistant Clinical Professor of Surgery

Vanderbilt University Medical Center

Founder & President, DADA2 Foundation

Registration will open in September

We will send an email when it is open

Patient Conference Track:

Reimagined in 2021

Patients are a critical component of our collaborative approach to understanding DADA2. However, with COVID restrictions, we are working on a virtual way to gather patients in 2021, or perhaps even a hybrid approach. We are in contact with a growing number of patients everyday and look forward to continuing our work together.

We look forward to seeing you soon!